alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 99.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In  connection  with the Annual Report of Magnitude  Information  Systems,
Inc. (the  "Company")  on Form 10-KSB for the year ended  December 31, 2003 (the
"Form 10-KSB"), I, Steven D. Rudnik, Chief Executive Officer of the Company, and
I, Joerg H. Klaube,  Chief Financial Officer of the Company,  certify, as of the
date hereof,  pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley  Act of 2002, that to the best of OUR knowledge,  that
the Company's Form 10-KSB fully complies with the  requirements of Section 13(a)
or  15(d) of the  Securities  Exchange  Act of 1934  and  that  the  information
contained in the Form 10-KSB,  fairly presents,  in all material  respects,  the
financial condition and results of operations of the Company.


Dated:  March 30, 2004      MAGNITUDE INFORMATION SYSTEMS, INC.

                                     By: /s/ Steven D. Rudnik
                                         ---------------------------------------
                                           Steven D. Rudnik
                                           President and Chief Executive Officer

                                     By: /s/ Joerg H. Klaube
                                         ---------------------------------------
                                          Joerg H. Klaube
                                          Chief   Financial Officer
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5187 Introduced in House (IH)]

109th CONGRESS
  2d Session
                                H. R. 5187

    To amend the John F. Kennedy Center Act to authorize additional 
 appropriations for the John F. Kennedy Center for the Performing Arts 
                         for fiscal year 2007.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 25, 2006

   Mr. Oberstar (for himself and Mr. Young of Alaska) introduced the 
 following bill; which was referred to the Committee on Transportation 
                           and Infrastructure

_______________________________________________________________________

                                 A BILL

 
    To amend the John F. Kennedy Center Act to authorize additional 
 appropriations for the John F. Kennedy Center for the Performing Arts 
                         for fiscal year 2007.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. JOHN F. KENNEDY CENTER FOR THE PERFORMING ARTS.

    (a) Maintenance, Repair, and Security.--Section 13(a) of the John 
F. Kennedy Center Act (20 U.S.C. 76r(a)) is amended--
            (1) in paragraph (1) by striking ``and'' at the end;
            (2) in paragraph (2) by striking ``, 2006, and 2007.'' and 
        inserting ``and 2006; and''; and
            (3) by adding at the end the following:
            ``(3) $19,100,000 for fiscal year 2007.''.
    (b) Capital Projects.--Section 13(b) of such Act (20 U.S.C. 76r(b)) 
is amended--
            (1) in paragraph (1) by striking ``and'' at the end;
            (2) in paragraph (2) by striking ``, 2006, and 2007.'' and 
        inserting ``and 2006; and''; and
            (3) by adding at the end the following:
            ``(3) $20,000,000 for fiscal year 2007.''.
                                 <all>
```
**Exhibit 32.1**

 

**CERTIFICATION**

 

 

Pursuant to 18 U.S.C. §1350, the undersigned officer of ING Life Insurance and Annuity Company (the “Company”) hereby certifies that, to the officer’s knowledge, the Company’s Annual Report on Form 10-K for the year ended December 31, 2008 (the “Report”) fully complies with the requirements of Section 13 or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

| March 24, 2009

  | By: /s/ | David A. Wheat                                                                                          |   |
|------------------------|---------|-------------------------------------------------------------------------------------------------------------------|--------|
| (Date)

          |    | David A. Wheat

Executive Vice President and 

Chief Financial Officer

  |   |

 

 

----
EXHIBIT 32

                                  CERTIFICATION
                                       OF
                             CHIEF EXECUTIVE OFFICER
                                       AND
                             CHIEF FINANCIAL OFFICER
                           PURSUANT TO 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         I, Li Jin  Yuan,  certify,  pursuant  to 18  U.S.C.  1350,  as  adopted
pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2003,  that the Quarterly
Report on Form 10-QSB of Tiens  Biotech  Group (USA),  Inc. for the period ended
September  30, 2004 fully  complies  with the  requirements  of Section 13(a) or
15(d) of the Securities  Exchange Act of 1934 and that information  contained in
such Quarterly Report on Form 10-QSB fairly presents,  in all material respects,
the financial  condition and results of operations of Tiens Biotech Group (USA),
Inc.

         I, Jiao  Wenjun,  certify,  pursuant  to 18  U.S.C.  1350,  as  adopted
pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002,  that the Quarterly
Report on Form 10-QSB of Tiens  Biotech  Group (USA),  Inc. for the period ended
September  30, 2004 fully  complies  with the  requirements  of Section 13(a) or
15(d) of the Securities  Exchange Act of 1934 and that information  contained in
such Quarterly Report on Form 10-QSB fairly presents,  in all material respects,
the financial  condition and results of operations of Tiens Biotech Group (USA),
Inc.

         Pursuant to the rules and  regulations  of the  Securities and Exchange
Commission, this certification is being furnished and is not deemed filed.




                                    By:   /s/ Li Jin Yuan
                                         ---------------------------------------
                                         Li Jin Yuan
                                         Chairman and Chief Executive Officer
                                         (Principal Executive Officer)

                                    By:   /s/ Jiao Wenjun
                                         ---------------------------------------
                                         Jiao Wenjun
                                         Chief Financial Officer
                                         (Principal Accounting Officer)

                                    Date:  November 15, 2004
No. 11-290.

#### Rick Charles Delacy, Petitioner v. California.

565 U.S. 1156, 132 S. Ct. 1092,

181 L. Ed. 2d 977,

2012 U.S. LEXIS 779.

January 17, 2012.

Petition for writ of certiorari to the Court of Appeal of California, First Appellate District, denied.

Same case below, 192 Cal. App. 4th 1481, 122 Cal. Rptr. 3d 216.
STATE of North Carolina v. Kenneth BREWER, Defendant.

No. COA18-1246

Court of Appeals of North Carolina.

Filed: August 6, 2019

NO ERROR.
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, James W. Bernau, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual
Report of Willamette Valley Vineyards Inc. on Form 10-KSB/A for the annual
period ended December 31, 2003 fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 and that information
contained in such 10-K fairly presents in all material respects the financial
condition and results of operations of Willamette Valley Vineyards Inc.

Date: December 6, 2004
By:	/s/
Name: James W. Bernau
Title:   Chief Executive Officer
PRINCIPLES o:
PROFESSIONAL ETHICS tor ine
INTELLIGENCE COMMUNITY

As members of the intelligence profession, we conduct ourselves in
accordance with certain basic principles. These principles are stated
below, and reflect the standard of ethical conduct expected of all
Intelligence Community personnel, regardless of individual role or agency
affiliation. Many of these principles are also reflected in other documents
that we look to for guidance, such as statements of core values, and the
Code of Conduct: Principles of Ethical Conduct for Government Officers
and Employees; it is nonetheless important for the Intelligence
Community to set forth in a single statement the fundamental ethical
principles that unite us and distinguish us as intelligence professionals.

MISSION We serve the American people, and understand that our
mission requires selfless dedication to the security of our Nation.

TRUTH We seek the truth; speak truth to power; and obtain, analyze, and
provide intelligence objectively.

LAWFULNESS We support and defend the Constitution, and comply with
the laws of the United States, ensuring that we carry out our mission in a
manner that respects privacy, civil liberties, and human rights
obligations.

INTEGRITY We demonstrate integrity in our conduct, mindful that all our
actions, whether public or not, should reflect positively on the
Intelligence Community at large.

STEWARDSHIP We are responsible stewards of the public trust; we use
intelligence authorities and resources prudently, protect intelligence
sources and methods diligently, report wrongdoing through appropriate
channels; and remain accountable to ourselves, our oversight
institutions, and through those institutions, ultimately to the American
people.

EXCELLENCE We seek to improve our performance and our craft
continuously, share information responsibly, collaborate with our
colleagues, and demonstrate innovation and agility when meeting new
challenges.

DIVERSITY We embrace the diversity of our Nation, promote diversity
and inclusion in our work force, and encourage diversity in our thinking.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Foreign Claims Settlement Commission 

The Foreign Claims Settlement Commission, pursuant to its regulations (45 CFR Part 504) and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice in regard to the scheduling of meetings for the transaction of Commission business and other matters specified, as follows: 

*Date and Time:*                     Wednesday, March 18, 2009, at 10:30 a.m.                 

*Subject Matter:*                     Issuance of Proposed Decisions, Amended Proposed Decisions, Final Decisions and Orders in claims against Albania.                 

*Status:*                     Open.                 

                    All meetings are held at the Foreign Claims Settlement Commission, 600 E Street, NW., Washington, DC. Requests for information, or advance notices of intention to observe an open meeting, may be directed to: Administrative Officer, Foreign Claims Settlement Commission, 600 E Street, NW., Room                           ( print page 10096)                        6002, Washington, DC 20579. Telephone: (202) 616-6975.                 

Mauricio J. Tamargo, 

Chairman.

[FR Doc. E9-4956 Filed 3-5-09; 11:15 am] 

BILLING CODE 4410-01-P
STATE of North Carolina v. Shane EVILSIZER

No. 181P19

Supreme Court of North Carolina.

June 11, 2019

Shane Evilsizer, for Evilsizer, Shane.

Daniel P. O'Brien, Special Deputy Attorney General, William R. West, District Attorney, for State of N.C.

***ORDER***

Upon consideration of the petition filed by Defendant on the 15th of May 2019 in this matter for a writ of certiorari to review the order of the Superior Court, Cumberland County, the following order was entered and is hereby certified to the Superior Court of that County:

"Dismissed by order of the Court in conference, this the 11th of June 2019."
I 

109TH CONGRESS 

2D SESSION H. R. 5155 

To provide for the release of certain land from the Sunrise Mountain Instant 

Study Area in the State of Nevada and to grant a right-of-way across 

the released land for the construction and maintenance of a flood control 

project. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 6, 2006 

Mr. PORTER (for himself, Mr. GIBBONS, and Ms. BERKLEY) introduced the 

following bill; which was referred to the Committee on Resources 

A BILL 

To provide for the release of certain land from the Sunrise 

Mountain Instant Study Area in the State of Nevada 

and to grant a right-of-way across the released land 

for the construction and maintenance of a flood control 

project. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Orchard Detention 

5 Basin Flood Control Act’’. 


cchase on PROD1PC60 with BILLS
2 

•HR 5155 IH 

1 SEC. 2. RELEASE OF CERTAIN LAND IN THE SUNRISE 

2 MOUNTAIN INSTANT STUDY AREA. 

3 (a) FINDING.—Congress finds that the land de4 scribed in subsection (c) has been adequately studied for 

5 wilderness designation under section 603 of the Federal 

6 Land Policy and Management Act of 1976 (43 U.S.C. 

7 1782). 

8 (b) RELEASE.—The land described in subsection 

9 (c)— 

10 (1) is no longer subject to section 603(c) of the 

11 Federal Land Policy and Management Act of 1976 

12 (43 U.S.C. 1782(c)); and 

13 (2) shall be managed in accordance with— 

14 (A) land management plans adopted under 

15 section 202 of that Act (43 U.S.C. 1712); and 

16 (B) cooperative conservation agreements in 

17 existence on the date of the enactment of this 

18 Act. 

19 (c) DESCRIPTION OF LAND.—The land referred to in 

20 subsections (a) and (b) is the approximately 65 acres of 

21 land in the Sunrise Mountain Instant Study Area of Clark 

22 County, Nevada, that is— 

23 (1) known as the ‘‘Orchard Detention Basin’’; 

24 and 


cchase on PROD1PC60 with BILLS
3 

•HR 5155 IH 

1 (2) designated for release on the map titled 

2 ‘‘Orchard Detention Basin’’ and dated March 18, 

3 2005. 

4 (d) RIGHT-OF-WAY.—The Secretary of the Interior 

5 shall grant to Clark County, Nevada, a right-of-way to the 

6 land described in subsection (c) for the construction and 

7 maintenance of the Orchard Detention Basin Project on 

8 the land. 

Æ 


cchase on PROD1PC60 with BILLS
Theron Lee MCLAMB, Petitioner, v. TOWN OF SMITHFIELD, Acting THROUGH ITS TOWN COUNCIL, Respondent.

No. COA18-1235

Court of Appeals of North Carolina.

Filed: June 4, 2019

AFFIRMED IN PART. REVERSED IN PART. REMANDED IN PART.
Exhibit
15.4









Consent
of Independent Registered Public Accounting Firm









We
consent to the incorporation by reference in Registration Statements No.
333-97481, No. 33-52722, and No. 33-92818
on      Form S-8 of our reports dated 24 February
2009 relating to the financial statements of Tomkins plc and the effectiveness
of Tomkins plc’s internal control over financial reporting appearing in
this Annual Report on Form 20-F of Tomkins plc for the year ended 3 January
2009.









/s/
Deloitte LLP





London,
United Kingdom


12 May
2009
No. 09-9664.

#### In re Wesley Allan Herring, Petitioner.

559 U.S. 1066, 130 S. Ct. 2129,

176 L. Ed. 2d 758,

2010 U.S. LEXIS 3145.

April 19, 2010.

Petition for writ of ha-beas corpus denied.
* Under 5 TH C IR

. R. 47.5, the Court has determined tha t this

opinion should not be published and is not precedent except in the limited circumstances set forth in 5 TH C IR . R. 47.5.4. UNITED STATES COURT OF APPEALS For the Fifth Circuit

No. 97-50989 Summary Calendar

CHARLES RAY COOPER,

Plaintiff-Appellant,

VERSUS

HONORABLE MICHAEL J. MC CORMICK, Judge, presiding judge of the Court of Criminal Appeals; TROY C. BENNETT, Clerk,

Defendants-Appellees.

Appeal from the United States District Court For the Western District of Texas

(A-96-CV-220)

June 24, 1998

Before BEFORE WISDOM, WIENER, and DENNIS, Circuit Judge.

PER CURIAM: *

Charles Ray Cooper, Texas prisoner #473763, filed a suit under

42 U.S.C. § 1983 in wh ich he alleged that Clerk Troy Bennett and

Justice Michael McCormick, both of the Texas Court of Criminal

Appeals, unconstitutionally denied him access to the courts. The

di strict court granted summary judgment for the defendants and,

finding Cooper’s claim to be frivolous, dismissed it under 282 See McCormick v. Stalder

, 105 F.3d 1059, 1061 (5th Cir.

1997).

2 U.S.C. § 1915(e)(2)(B). Cooper timely filed notice of appeal. We

affirm.

On September 4, 1995, Cooper submitted six copies of a

petition for habeas corpus relief to the Texas Court of Criminal

Appeals. The following month, Clerk Bennett sent Cooper a letter

in which he advised Cooper that he was required to file the

petition in the trial court. Cooper responded by letter, stating

that “if [Cooper’ s] gonna construct the plaintiff’s writ, then

consider it as a mandamus.” Bennett did not respond to this

letter. By Cooper’s reasoning, Bennett’s conduct

unconstitutionally hindered his access to the courts.

The district court conc luded that Cooper’s lawsuit was

“absolutely ludicrous,” and that the parties had “spent over one

year litigating [a] non-issue.” We could not agree more. Cooper

has not alleged that Justice McCormick did anything to violate his

constitutional rights. There is not a shred of evidence that

Justice McCormick ever came into contact with the petition Cooper

attempted to file with the Texas Court of Criminal Appeals.

Furthermore, the district c ourt did not abuse its discretion in

concluding that Coope r’s claim against Clerk Bennett was

frivolo us. 2 Indeed, Bennett acted reasonably in advising Cooper

that he was required to file his petition for habeas relief in the

trial court.3

AFFIRMED.
STATE v. Jennifer JIMENEZ/April Myers

22P19-3

Supreme Court of North Carolina.

August 14, 2019

April Myers, For Jimenez, Jennifer

James R. O'Neill, District Attorney, For the State of North Carolina.

The following order has been entered on the motion filed on the 25th of June 2019 by Defendant to Recall Order for Arrest; Failure to Appear; Strike Called and Failed; and to Set Aside Bond Forfeiture:

"Motion Dismissed by order of the Court in conference, this the 14th of August 2019."
<PAGE>
                                                                    EXHIBIT 23.1
 
                       CONSENT OF INDEPENDENT ACCOUNTANTS
 
    We consent to the incorporation by reference in the registration statements
of Genus, Inc. and subsidiaries on Form S-8 (File Nos. 33-28394, 33-38657,
33-56192 and 333-29999) of our report, which includes an explanatory paragraph
regarding the Company's ability to continue as a going concern, dated January
26, 1998, except for Notes 1, 5 and 16 as to which the date is March 2, 1998,
and of our report dated January 26, 1998, on our audits of the consolidated
financial statements and financial statement schedule, respectively, of Genus,
Inc. and subsidiaries as of December 31, 1997 and 1996, and for each of the
three years in the period ended December 31, 1997, which reports are included in
this Annual Report on Form 10-K/A.
 
                                          COOPERS & LYBRAND L.L.P.
 
San Jose, California
April 28, 1998
STATE of North Carolina v. Cecil Dewayne MCANINCH, Defendant.

No. COA18-852

Court of Appeals of North Carolina.

Filed: August 20, 2019

NO ERROR.
STATE v. Ronald Thompson CORBETT

317P16-3

Supreme Court of North Carolina.

August 14, 2019

Ronald Thompson Corbett, Lumberton, For Corbett, Ronald Thompson

Josephine N. Tetteh, Assistant Attorney General, For State of N.C.

Mark L. Hayes, Attorney at Law, For Corbett, Ronald Thompson

N. Lorrin Freeman, District Attorney, For State of N.C.

The following order has been entered on the motion filed on the 4th of April 2019 by Defendant to Make Appeal Private and Sealed:

"Motion Dismissed as moot by order of the Court in conference, this the 14th of August 2019."

Davis, J., recused
# C_2016490EN.01001301.xml

| 30.12.2016 | EN | Official Journal of the European Union | C 490/13 |
| --- | --- | --- | --- |

30.12.2016

EN

Official Journal of the European Union

C 490/13

---

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2016 to 29 February 2016

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))

1

(2016/C 490/03)

—   Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Rejected

Issuing of a marketing authorization

Rejected

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 11.2.2016 | Solumarv | Marvel Lifesciences Limited
  Congress House Lyon Road HA1 2EN Harrow United Kingdom | — | 15.2.2016 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

11.2.2016

Solumarv

Marvel Lifesciences Limited

Congress House Lyon Road HA1 2EN Harrow United Kingdom

—

15.2.2016

—   Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Modification of a marketing authorization

Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 11.2.2016 | Tybost | Gilead Sciences International Limited
  Cambridge CB21 6GT, United Kingdom | EU/1/13/872 | 7.3.2016 |
| 26.2.2016 | Clopidogrel Zentiva | Sanofi-Aventis groupe
  54 rue La Boétie, F-75008 Paris, France | EU/1/08/465 | 1.3.2016 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

11.2.2016

Tybost

Gilead Sciences International Limited

Cambridge CB21 6GT, United Kingdom

EU/1/13/872

7.3.2016

26.2.2016

Clopidogrel Zentiva

Sanofi-Aventis groupe

54 rue La Boétie, F-75008 Paris, France

EU/1/08/465

1.3.2016

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| European Medicines Agency |
| --- |
| 30 Churchill Place |
| Canary Wharf |
| London E14 5EU |
| United Kingdom |

European Medicines Agency

30 Churchill Place

Canary Wharf

London E14 5EU

United Kingdom

---

(1)  OJ L 136, 30.4.2004, p. 1.

1

---